Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 31

1.

Membrane-anchored CCL20 augments HIV Env-specific mucosal immune responses.

Sun X, Zhang H, Xu S, Shi L, Dong J, Gao D, Chen Y, Feng H.

Virol J. 2017 Aug 23;14(1):163. doi: 10.1186/s12985-017-0831-4.

2.

Vaccine-induced immune responses against both Gag and Env improve control of simian immunodeficiency virus replication in rectally challenged rhesus macaques.

Martins MA, Shin YC, Gonzalez-Nieto L, Domingues A, Gutman MJ, Maxwell HS, Castro I, Magnani DM, Ricciardi M, Pedreño-Lopez N, Bailey V, Betancourt D, Altman JD, Pauthner M, Burton DR, von Bredow B, Evans DT, Yuan M, Parks CL, Ejima K, Allison DB, Rakasz E, Barber GN, Capuano S 3rd, Lifson JD, Desrosiers RC, Watkins DI.

PLoS Pathog. 2017 Jul 21;13(7):e1006529. doi: 10.1371/journal.ppat.1006529. eCollection 2017 Jul.

3.

The evolution of poxvirus vaccines.

Sánchez-Sampedro L, Perdiguero B, Mejías-Pérez E, García-Arriaza J, Di Pilato M, Esteban M.

Viruses. 2015 Apr 7;7(4):1726-803. doi: 10.3390/v7041726. Review.

4.

The influence of delivery vectors on HIV vaccine efficacy.

Ondondo BO.

Front Microbiol. 2014 Aug 22;5:439. doi: 10.3389/fmicb.2014.00439. eCollection 2014. Review.

5.

Challenges in mucosal HIV vaccine development: lessons from non-human primate models.

Tuero I, Robert-Guroff M.

Viruses. 2014 Aug 15;6(8):3129-58. doi: 10.3390/v6083129. Review.

6.

Recombinant Mycobacterium bovis bacillus Calmette-Guérin vectors prime for strong cellular responses to simian immunodeficiency virus gag in rhesus macaques.

Sixsmith JD, Panas MW, Lee S, Gillard GO, White K, Lifton MA, Balachandran H, Mach L, Miller JP, Lavine C, DeMarco CT, Tomaras GD, Gee C, Porcelli SA, Larsen MH, Frothingham R, Schmitz JE, Jacobs WR Jr, Haynes BF, Letvin NL, Korioth-Schmitz B.

Clin Vaccine Immunol. 2014 Oct;21(10):1385-95. doi: 10.1128/CVI.00324-14. Epub 2014 Jul 30.

7.
8.

Nonhuman primate models for HIV/AIDS vaccine development.

Sui Y, Gordon S, Franchini G, Berzofsky JA.

Curr Protoc Immunol. 2013 Oct 1;102:Unit 12.14.. doi: 10.1002/0471142735.im1214s102. Review.

9.

Tissue competence imprinting and tissue residency of CD8 T cells.

Krzysiek R, de Goër de Herve MG, Yang H, Taoufik Y.

Front Immunol. 2013 Sep 17;4:283. doi: 10.3389/fimmu.2013.00283. Review.

10.

HIV vaccine research and discovery in the nonhuman primates model: a unified theory in acquisition prevention and control of SIV infection.

Lynch RM, Yamamoto T, McDermott AB.

Curr Opin HIV AIDS. 2013 Jul;8(4):288-94. doi: 10.1097/COH.0b013e328361cfe8. Review.

11.

The dynamic lives of T cells: new approaches and themes.

Yamanaka YJ, Gierahn TM, Love JC.

Trends Immunol. 2013 Feb;34(2):59-66. doi: 10.1016/j.it.2012.10.006. Epub 2012 Nov 28. Review.

12.

Menstrual blood as a potential source of endometrial derived CD3+ T cells.

Sabbaj S, Hel Z, Richter HE, Mestecky J, Goepfert PA.

PLoS One. 2011;6(12):e28894. doi: 10.1371/journal.pone.0028894. Epub 2011 Dec 9.

13.

The development of an AIDS mucosal vaccine.

Tang X, Chen Z.

Viruses. 2010 Jan;2(1):283-97. doi: 10.3390/v2010283. Epub 2010 Jan 22.

14.

Durable mucosal simian immunodeficiency virus-specific effector memory T lymphocyte responses elicited by recombinant adenovirus vectors in rhesus monkeys.

Li H, Liu J, Carville A, Mansfield KG, Lynch D, Barouch DH.

J Virol. 2011 Nov;85(21):11007-15. doi: 10.1128/JVI.05346-11. Epub 2011 Sep 14.

15.

Both systemic and mucosal LCMV immunization generate robust viral-specific IgG in mucosal secretions, but elicit poor LCMV-specific IgA.

Rajini B, Zeng J, Suvas PK, Dech HM, Onami TM.

Viral Immunol. 2010 Aug;23(4):377-84. doi: 10.1089/vim.2010.0012.

16.

Mucosal HIV transmission and vaccination strategies through oral compared with vaginal and rectal routes.

Yu M, Vajdy M.

Expert Opin Biol Ther. 2010 Aug;10(8):1181-95. doi: 10.1517/14712598.2010.496776. Review.

17.

Long-lasting humoral and cellular immune responses and mucosal dissemination after intramuscular DNA immunization.

Patel V, Valentin A, Kulkarni V, Rosati M, Bergamaschi C, Jalah R, Alicea C, Minang JT, Trivett MT, Ohlen C, Zhao J, Robert-Guroff M, Khan AS, Draghia-Akli R, Felber BK, Pavlakis GN.

Vaccine. 2010 Jul 5;28(30):4827-36. doi: 10.1016/j.vaccine.2010.04.064. Epub 2010 May 6.

18.

Route of adenovirus-based HIV-1 vaccine delivery impacts the phenotype and trafficking of vaccine-elicited CD8+ T lymphocytes.

Kaufman DR, Bivas-Benita M, Simmons NL, Miller D, Barouch DH.

J Virol. 2010 Jun;84(12):5986-96. doi: 10.1128/JVI.02563-09. Epub 2010 Mar 31.

19.

Dynamic T cell migration program provides resident memory within intestinal epithelium.

Masopust D, Choo D, Vezys V, Wherry EJ, Duraiswamy J, Akondy R, Wang J, Casey KA, Barber DL, Kawamura KS, Fraser KA, Webby RJ, Brinkmann V, Butcher EC, Newell KA, Ahmed R.

J Exp Med. 2010 Mar 15;207(3):553-64. doi: 10.1084/jem.20090858. Epub 2010 Feb 15.

20.

Translational Mini-Review Series on Vaccines for HIV: T lymphocyte trafficking and vaccine-elicited mucosal immunity.

Kaufman DR, Barouch DH.

Clin Exp Immunol. 2009 Aug;157(2):165-73. doi: 10.1111/j.1365-2249.2009.03927.x. Review.

Supplemental Content

Support Center